Exemestane or Docetaxel-Cytoxan in Low Recurrence Score Cancers
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Exemestane|DRUG: Docetaxel|DRUG: Cytoxan
Sponsor: Emory University
Collaborators: Pfizer